| Ruxolitinib |
鲁索利替尼 |
941678-49-5 |
| 1-(4-ethylphenyl)-3-(1H-indol-3-yl)urea |
H-151 |
941987-60-6 |
| 4-[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[(3S)-3-piperidinylmethoxy]-1H-imidazo[4,5-c]pyridin-4-yl]-2-methyl-3-butyn-2-ol |
4-[2-(4-氨基-1,2,5-恶二唑-3-基)-1-乙基-7-[(3S)-3-哌啶基甲氧基]-1H-咪唑并[4,5-C]吡啶-4-基]-2-甲基-3-丁炔-2-醇 |
937174-76-0 |
| NVP-BHG712 |
4-甲基-3-[[1-甲基-6-(3-吡啶基)-1H-吡唑并[3,4-D]嘧啶-4-基]氨基]-N-[3-(三氟甲基)苯基]苯甲酰胺 |
940310-85-0 |
| ABT 263 |
ABT 263 |
923564-51-6 |
| Nifuroxazide |
硝呋酚酰肼 |
965-52-6 |
| Bafetinib |
巴非替尼 |
887650-05-7 |
| Ro 3306 |
2-[[(噻吩-2-基)甲基]氨基]-5-[1-(喹啉-6-基)甲-(Z)-亚基]噻唑-4-酮 |
872573-93-8 |
| Boc-Val-Cit-PAB-PNP |
Boc-Val-Cit-PAB-PNP |
870487-10-8 |
| FMoc-Val-Cit-PAB-PNP |
FMoc-Val-Cit-PAB-PNP |
863971-53-3 |
| MALAT1 inhibitor 5
(Malat1 inhibitor 5) |
MALAT1 inhibitor 5
(Malat1 inhibitor 5) |
827327-28-6 |
| AS1842856 |
5-氨基-7-(环己基氨基)-1-乙基-6-氟-1,4-二氢-4-氧代-3-喹啉羧酸 |
836620-48-5 |
| GNF5 |
GNF-5 |
778277-15-9 |
| EHT1864 |
EHT 1864 |
754240-09-0 |
| Chidamide |
西达本胺 |
743420-02-2 |
| N-[3-[[5-Iodo-4-[[3-[(2-thienylcarbonyl)amino]propyl]amino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide |
N-[3-[[5-碘-4-[[3-[(2-噻吩基羰基)氨基]丙基]氨基]-2-嘧啶基]氨基]苯基]-1-吡咯烷甲酰胺 |
702675-74-9 |
| 6-THIO-2'-DEOXYGUANOSINE |
6-巯基-2'-脱氧鸟苷 |
789-61-7 |
| JW55 |
JW-55 |
664993-53-7 |
| Sb-742457 |
3-苯基磺酰基-8-(哌嗪-1-基)喹啉 |
607742-69-8 |
| Cadralazine |
卡屈嗪 |
64241-34-5 |
QQ
微信
